Check out Pro
Top Companies
Recent Trades
Cluster Buys
Sectors
Blog
Join the Insiderviz Pro waitlist
BridgeBio Pharma, Inc. (BBIO)
All trades on this company by insiders. Hover over bubbles for specific trade details. Drag along the graph for custom price change. Green - Buy, Red - Sell, Orange - Congress Member.
Healthcare
Biotechnology
DATE
INSIDER
COMPANY
OWNED SHARES
SHARES TRADED
PRICE
NET TOTAL
SELL
1 Mar 2024
Scott Randal W.
Director
BridgeBio Pharma, Inc.
(BBIO)
6,500
-27%
2,500
$34.00
$85,000.00
SELL
15 Feb 2024
Valantine Hannah
Director
BridgeBio Pharma, Inc.
(BBIO)
1,764
-62%
2,915
$37.75
$110,041.25
SELL
16 Jan 2024
Valantine Hannah
Director
BridgeBio Pharma, Inc.
(BBIO)
1,764
-62%
2,915
$37.97
$110,682.56
SELL
26 Dec 2023
MCCORMICK FRANK
Director
BridgeBio Pharma, Inc.
(BBIO)
627,689
-13%
100,000
$42.06
$4,206,000.00
SELL
18 Dec 2023
Scott Randal W.
Director
BridgeBio Pharma, Inc.
(BBIO)
9,000
-18%
2,000
$40.00
$80,000.00
SELL
15 Dec 2023
Valantine Hannah
Director
BridgeBio Pharma, Inc.
(BBIO)
1,764
-62%
2,915
$36.12
$105,289.80
SELL
16 Nov 2023
STEPHENSON BRIAN C
Secretary, Treasurer & CFO, Officer
BridgeBio Pharma, Inc.
(BBIO)
36,710
-38%
22,685
$29.10
$660,058.60
SELL
16 Nov 2023
Kumar Neil
CEO and President, Director, Officer
BridgeBio Pharma, Inc.
(BBIO)
4,813,397
-1%
51,552
$29.10
$1,500,037.50
SELL
15 Nov 2023
Valantine Hannah
Director
BridgeBio Pharma, Inc.
(BBIO)
1,764
-62%
2,915
$30.00
$87,450.00
SELL
5 Sep 2023
Scott Randal W.
Director
BridgeBio Pharma, Inc.
(BBIO)
13,500
-15%
2,500
$30.00
$75,000.00
SELL
16 Aug 2023
STEPHENSON BRIAN C
Secretary, Treasurer & CFO, Officer
BridgeBio Pharma, Inc.
(BBIO)
36,710
-38%
22,683
$28.59
$648,454.80
SELL
16 Aug 2023
Kumar Neil
CEO and President, Director, Officer
BridgeBio Pharma, Inc.
(BBIO)
4,813,197
-1%
51,552
$28.59
$1,473,784.10
SELL
16 May 2023
STEPHENSON BRIAN C
Secretary, Treasurer & CFO, Officer
BridgeBio Pharma, Inc.
(BBIO)
36,408
-40%
24,424
$14.01
$342,168.03
SELL
16 May 2023
Kumar Neil
CEO and President, Director, Officer
BridgeBio Pharma, Inc.
(BBIO)
4,813,197
-1%
51,552
$14.01
$722,217.75
SELL
3 May 2023
STEPHENSON BRIAN C
Secretary, Treasurer & CFO, Officer
BridgeBio Pharma, Inc.
(BBIO)
36,408
-64%
64,929
$14.18
$920,693.25
SELL
3 May 2023
Kumar Neil
CEO and President, Director, Officer
BridgeBio Pharma, Inc.
(BBIO)
1,012,722
-10%
120,000
$14.18
$1,701,744.00
SELL
5 Apr 2023
Kumar Neil
CEO and President, Director, Officer
BridgeBio Pharma, Inc.
(BBIO)
1,132,722
-9%
120,000
$15.46
$1,855,656.00
SELL
5 Apr 2023
STEPHENSON BRIAN C
Secretary, Treasurer & CFO, Officer
BridgeBio Pharma, Inc.
(BBIO)
101,337
-35%
55,500
$15.45
$857,697.00
SELL
3 Mar 2023
Kumar Neil
CEO and President, Director, Officer
BridgeBio Pharma, Inc.
(BBIO)
1,252,722
-8%
120,000
$10.96
$1,315,224.00
SELL
3 Mar 2023
STEPHENSON BRIAN C
Secretary, Treasurer & CFO, Officer
BridgeBio Pharma, Inc.
(BBIO)
156,837
-28%
62,692
$10.96
$687,148.20
SELL
16 Feb 2023
Kumar Neil
CEO and President, Director, Officer
BridgeBio Pharma, Inc.
(BBIO)
4,813,197
-0%
44,798
$12.70
$569,073.50
SELL
16 Feb 2023
STEPHENSON BRIAN C
Secretary, Treasurer & CFO, Officer
BridgeBio Pharma, Inc.
(BBIO)
221,679
-7%
17,717
$12.70
$225,065.92
SELL
3 Feb 2023
Kumar Neil
CEO and President, Director, Officer
BridgeBio Pharma, Inc.
(BBIO)
1,372,722
-8%
120,000
$11.01
$1,320,696.00
SELL
3 Feb 2023
STEPHENSON BRIAN C
Secretary, Treasurer & CFO, Officer
BridgeBio Pharma, Inc.
(BBIO)
219,184
-21%
61,040
$11.01
$671,922.25
SELL
5 Jan 2023
Kumar Neil
CEO and President, Director, Officer
BridgeBio Pharma, Inc.
(BBIO)
1,492,722
-7%
120,000
$7.67
$920,856.00
SELL
5 Jan 2023
STEPHENSON BRIAN C
Secretary, Treasurer & CFO, Officer
BridgeBio Pharma, Inc.
(BBIO)
280,224
-17%
61,040
$7.67
$468,469.78
SELL
16 Nov 2022
STEPHENSON BRIAN C
Secretary, Treasurer & CFO, Officer
BridgeBio Pharma, Inc.
(BBIO)
341,264
-5%
19,678
$9.40
$184,985.02
SELL
16 Nov 2022
Kumar Neil
CEO and President, Director, Officer
BridgeBio Pharma, Inc.
(BBIO)
4,813,197
-0%
34,640
$9.40
$325,605.62
BUY
15 Mar 2022
Ellis Andrea
Director
BridgeBio Pharma, Inc.
(BBIO)
12,000
+100%
12,000
$8.39
$100,680.01
BUY
14 Mar 2022
Dachille Douglas A.
Director
BridgeBio Pharma, Inc.
(BBIO)
20,000
+100%
10,000
$8.19
$81,934.00
BUY
4 Jan 2022
Dachille Douglas A.
Director
BridgeBio Pharma, Inc.
(BBIO)
10,000
+100%
10,000
$16.37
$163,650.00
BUY
29 Dec 2021
SAUNDERS BRENT L
Director
BridgeBio Pharma, Inc.
(BBIO)
17,600
+100%
17,600
$14.48
$254,879.69
BUY
29 Dec 2021
Hassan Fred
Director
BridgeBio Pharma, Inc.
(BBIO)
19,300
+100%
19,300
$14.17
$273,390.30
BUY
29 Dec 2021
Valantine Hannah
Director
BridgeBio Pharma, Inc.
(BBIO)
1,764
+100%
1,764
$14.23
$25,101.72
BUY
29 Dec 2021
Lo Andrew
Director
BridgeBio Pharma, Inc.
(BBIO)
48,099
+18%
7,500
$13.18
$98,850.00
BUY
29 Dec 2021
MOMTAZEE JAMES C
Director
BridgeBio Pharma, Inc.
(BBIO)
88,491
+942%
80,000
$14.50
$1,160,000.00
BUY
28 Dec 2021
DANIELS RONALD J
Director
BridgeBio Pharma, Inc.
(BBIO)
10,402
+100%
10,402
$13.25
$148,342.53
BUY
28 Dec 2021
Valantine Hannah
Director
BridgeBio Pharma, Inc.
(BBIO)
1,891
+222%
3,433
$12.96
$44,475.94
SELL
4 Aug 2021
SCHELLER RICHARD H
See Remarks, Director, Officer
BridgeBio Pharma, Inc.
(BBIO)
45,860
-23%
13,777
$53.23
$733,316.60
SELL
17 Feb 2021
KKR Genetic Disorder L.P.
10% Owner
BridgeBio Pharma, Inc.
(BBIO)
31,060,972
-9%
3,450,000
$60.47
$208,617,360.00
BUY
17 Feb 2021
Scott Randal W.
Director
BridgeBio Pharma, Inc.
(BBIO)
21,000
+320%
16,000
$62.50
$1,000,000.00
BUY
16 Feb 2021
STEPHENSON BRIAN C
See Remarks, Officer
BridgeBio Pharma, Inc.
(BBIO)
300,043
+2%
8,000
$62.50
$500,000.00
SELL
28 Dec 2020
Turtle Cameron
See Remarks, Officer
BridgeBio Pharma, Inc.
(BBIO)
21,131
-47%
19,500
$69.60
$1,357,184.00
SELL
21 Dec 2020
SCHELLER RICHARD H
See Remarks, Director, Officer
BridgeBio Pharma, Inc.
(BBIO)
91,333
-39%
60,401
$65.32
$3,945,137.00
SELL
18 Dec 2020
SCHELLER RICHARD H
See Remarks, Director, Officer
BridgeBio Pharma, Inc.
(BBIO)
109,156
-21%
30,000
$65.07
$1,952,020.90
SELL
15 Dec 2020
SCHELLER RICHARD H
See Remarks, Director, Officer
BridgeBio Pharma, Inc.
(BBIO)
155,613
-16%
31,443
$60.38
$1,898,417.20
SELL
1 Dec 2020
HENDERSON MICHAEL THOMAS
Chief Business Officer, Officer
BridgeBio Pharma, Inc.
(BBIO)
281,183
-3%
10,000
$51.52
$515,204.06
SELL
24 Nov 2020
Turtle Cameron
See Remarks, Officer
BridgeBio Pharma, Inc.
(BBIO)
12,568
-28%
5,000
$47.04
$235,180.84
SELL
16 Nov 2020
HENDERSON MICHAEL THOMAS
Chief Business Officer, Officer
BridgeBio Pharma, Inc.
(BBIO)
267,751
-3%
10,000
$45.00
$450,000.00
SELL
13 Nov 2020
MCCORMICK FRANK
Chairman of Oncology, Officer
BridgeBio Pharma, Inc.
(BBIO)
1,268,836
-7%
100,000
$42.76
$4,275,769.00
SELL
5 Nov 2020
Turtle Cameron
See Remarks, Officer
BridgeBio Pharma, Inc.
(BBIO)
12,568
-16%
2,500
$42.05
$105,124.75
SELL
2 Nov 2020
HENDERSON MICHAEL THOMAS
Chief Business Officer, Officer
BridgeBio Pharma, Inc.
(BBIO)
268,251
-3%
10,000
$38.36
$383,557.70
SELL
16 Oct 2020
HOMCY CHARLES J
Chairman of Pharmaceuticals, Director, Officer
BridgeBio Pharma, Inc.
(BBIO)
1,203,767
-0%
10,256
$41.00
$420,496.00
SELL
1 Oct 2020
HENDERSON MICHAEL THOMAS
Chief Business Officer, Officer
BridgeBio Pharma, Inc.
(BBIO)
273,256
-3%
10,000
$38.83
$388,341.84
SELL
30 Sep 2020
Turtle Cameron
See Remarks, Officer
BridgeBio Pharma, Inc.
(BBIO)
14,626
-49%
14,500
$37.69
$546,457.75
SELL
30 Sep 2020
HOMCY CHARLES J
Chairman of Pharmaceuticals, Director, Officer
BridgeBio Pharma, Inc.
(BBIO)
1,203,767
-0%
10,000
$38.00
$380,000.00
SELL
25 Sep 2020
HOMCY CHARLES J
Chairman of Pharmaceuticals, Director, Officer
BridgeBio Pharma, Inc.
(BBIO)
1,203,767
-7%
99,257
$36.95
$3,667,955.00
SELL
18 Sep 2020
Turtle Cameron
See Remarks, Officer
BridgeBio Pharma, Inc.
(BBIO)
12,568
-16%
2,500
$42.01
$105,024.25
SELL
18 Sep 2020
HENDERSON MICHAEL THOMAS
Chief Business Officer, Officer
BridgeBio Pharma, Inc.
(BBIO)
267,751
-3%
10,000
$40.00
$400,000.00
SELL
16 Sep 2020
SCHELLER RICHARD H
See Remarks, Director, Officer
BridgeBio Pharma, Inc.
(BBIO)
138,427
-15%
25,000
$37.50
$937,500.00
SELL
15 Sep 2020
Turtle Cameron
See Remarks, Officer
BridgeBio Pharma, Inc.
(BBIO)
12,568
-16%
2,500
$37.06
$92,651.75
SELL
11 Sep 2020
Turtle Cameron
See Remarks, Officer
BridgeBio Pharma, Inc.
(BBIO)
12,568
-13%
2,000
$35.02
$70,047.00
SELL
1 Sep 2020
HENDERSON MICHAEL THOMAS
Chief Business Officer, Officer
BridgeBio Pharma, Inc.
(BBIO)
272,729
-3%
10,000
$28.73
$287,334.40
SELL
3 Aug 2020
HENDERSON MICHAEL THOMAS
Chief Business Officer, Officer
BridgeBio Pharma, Inc.
(BBIO)
261,396
-3%
10,000
$27.37
$273,740.75
SELL
3 Aug 2020
Kumar Neil
CEO and President, Director, Officer
BridgeBio Pharma, Inc.
(BBIO)
2,092,131
-3%
80,000
$27.23
$2,178,066.00
SELL
3 Aug 2020
STEPHENSON BRIAN C
See Remarks, Officer
BridgeBio Pharma, Inc.
(BBIO)
287,519
-2%
7,200
$27.26
$196,288.64
SELL
1 Jul 2020
HENDERSON MICHAEL THOMAS
Chief Business Officer, Officer
BridgeBio Pharma, Inc.
(BBIO)
263,125
-3%
10,000
$30.97
$309,701.25
SELL
1 Jul 2020
Kumar Neil
CEO and President, Director, Officer
BridgeBio Pharma, Inc.
(BBIO)
2,165,372
-6%
143,470
$30.75
$4,411,357.00
SELL
1 Jul 2020
STEPHENSON BRIAN C
See Remarks, Officer
BridgeBio Pharma, Inc.
(BBIO)
297,216
-3%
10,800
$30.93
$334,052.70
SELL
30 Jun 2020
Turtle Cameron
See Remarks, Officer
BridgeBio Pharma, Inc.
(BBIO)
10,123
-49%
10,000
$32.66
$326,623.03
SELL
8 Jun 2020
HENDERSON MICHAEL THOMAS
Chief Business Officer, Officer
BridgeBio Pharma, Inc.
(BBIO)
260,393
-0%
606
$30.01
$18,185.25
SELL
8 Jun 2020
Kumar Neil
CEO and President, Director, Officer
BridgeBio Pharma, Inc.
(BBIO)
2,308,842
-0%
10,600
$30.01
$318,125.10
SELL
8 Jun 2020
STEPHENSON BRIAN C
See Remarks, Officer
BridgeBio Pharma, Inc.
(BBIO)
305,116
-0%
2,000
$30.00
$60,001.60
SELL
3 Jun 2020
HENDERSON MICHAEL THOMAS
Chief Business Officer, Officer
BridgeBio Pharma, Inc.
(BBIO)
261,399
-0%
784
$30.04
$23,548.54
SELL
3 Jun 2020
Kumar Neil
CEO and President, Director, Officer
BridgeBio Pharma, Inc.
(BBIO)
2,319,442
-0%
5,930
$30.05
$178,173.38
SELL
3 Jun 2020
STEPHENSON BRIAN C
See Remarks, Officer
BridgeBio Pharma, Inc.
(BBIO)
307,116
-0%
1,600
$30.04
$48,071.84
SELL
1 Jun 2020
HENDERSON MICHAEL THOMAS
Chief Business Officer, Officer
BridgeBio Pharma, Inc.
(BBIO)
262,183
-0%
2,585
$29.37
$75,911.65
SELL
1 Jun 2020
Kumar Neil
CEO and President, Director, Officer
BridgeBio Pharma, Inc.
(BBIO)
2,334,081
-3%
80,000
$29.19
$2,335,389.80
SELL
1 Jun 2020
STEPHENSON BRIAN C
See Remarks, Officer
BridgeBio Pharma, Inc.
(BBIO)
309,616
-2%
7,200
$29.36
$211,400.90
SELL
28 May 2020
KKR Genetic Disorder L.P.
10% Owner
BridgeBio Pharma, Inc.
(BBIO)
34,510,972
-6%
2,389,690
$33.39
$79,791,740.00
SELL
5 May 2020
HENDERSON MICHAEL THOMAS
See Remarks, Officer
BridgeBio Pharma, Inc.
(BBIO)
162,362
-0%
1,460
$30.47
$44,493.35
SELL
5 May 2020
Kumar Neil
CEO and President, Director, Officer
BridgeBio Pharma, Inc.
(BBIO)
2,440,206
-3%
79,600
$31.02
$2,469,482.00
SELL
5 May 2020
STEPHENSON BRIAN C
See Remarks, Officer
BridgeBio Pharma, Inc.
(BBIO)
315,916
-1%
5,706
$30.49
$173,959.39
SELL
1 May 2020
HENDERSON MICHAEL THOMAS
See Remarks, Officer
BridgeBio Pharma, Inc.
(BBIO)
163,822
-2%
3,905
$29.52
$115,266.78
SELL
1 May 2020
Kumar Neil
CEO and President, Director, Officer
BridgeBio Pharma, Inc.
(BBIO)
2,518,946
-3%
80,400
$29.40
$2,364,085.00
SELL
1 May 2020
STEPHENSON BRIAN C
See Remarks, Officer
BridgeBio Pharma, Inc.
(BBIO)
321,622
-2%
8,694
$29.37
$255,301.53
SELL
27 Apr 2020
Turtle Cameron
See Remarks, Officer
BridgeBio Pharma, Inc.
(BBIO)
9,823
-16%
2,000
$32.01
$64,027.60
SELL
8 Apr 2020
Turtle Cameron
See Remarks, Officer
BridgeBio Pharma, Inc.
(BBIO)
9,823
-44%
8,000
$27.04
$216,357.61
SELL
7 Apr 2020
Kumar Neil
CEO and President, Director, Officer
BridgeBio Pharma, Inc.
(BBIO)
2,565,372
-0%
1,805
$25.48
$45,983.10
SELL
3 Apr 2020
Kumar Neil
CEO and President, Director, Officer
BridgeBio Pharma, Inc.
(BBIO)
2,567,277
-0%
300
$25.09
$7,528.00
SELL
1 Apr 2020
HENDERSON MICHAEL THOMAS
See Remarks, Officer
BridgeBio Pharma, Inc.
(BBIO)
170,268
-1%
2,585
$26.94
$69,629.23
SELL
1 Apr 2020
Kumar Neil
CEO and President, Director, Officer
BridgeBio Pharma, Inc.
(BBIO)
2,567,477
-2%
77,895
$26.02
$2,026,465.80
SELL
1 Apr 2020
STEPHENSON BRIAN C
See Remarks, Officer
BridgeBio Pharma, Inc.
(BBIO)
334,102
-2%
7,200
$26.61
$191,609.56
SELL
2 Mar 2020
HENDERSON MICHAEL THOMAS
See Remarks, Officer
BridgeBio Pharma, Inc.
(BBIO)
171,712
-2%
3,975
$32.44
$128,965.20
SELL
2 Mar 2020
Kumar Neil
CEO and President, Director, Officer
BridgeBio Pharma, Inc.
(BBIO)
2,657,663
-4%
120,000
$32.28
$3,874,030.20
SELL
2 Mar 2020
STEPHENSON BRIAN C
See Remark, Officer
BridgeBio Pharma, Inc.
(BBIO)
343,356
-3%
10,800
$32.27
$348,540.97
SELL
11 Feb 2020
Turtle Cameron
See Remarks, Officer
BridgeBio Pharma, Inc.
(BBIO)
9,823
-16%
2,000
$37.28
$74,564.20
SELL
10 Feb 2020
HOMCY CHARLES J
Chairman of Pharmaceuticals, Director, Officer
BridgeBio Pharma, Inc.
(BBIO)
1,342,291
-1%
20,000
$36.00
$720,000.00
SELL
5 Feb 2020
Kumar Neil
CEO and President, Director, Officer
BridgeBio Pharma, Inc.
(BBIO)
2,765,372
-1%
30,893
$34.87
$1,077,390.20
SELL
3 Feb 2020
HENDERSON MICHAEL THOMAS
See Remarks, Officer
BridgeBio Pharma, Inc.
(BBIO)
174,287
-2%
3,975
$34.90
$138,729.50
SELL
3 Feb 2020
Kumar Neil
See Remarks, Director, Officer
BridgeBio Pharma, Inc.
(BBIO)
2,796,265
-3%
89,107
$34.70
$3,091,610.00
SELL
3 Feb 2020
STEPHENSON BRIAN C
See Remarks, Officer
BridgeBio Pharma, Inc.
(BBIO)
348,316
-3%
10,800
$34.73
$375,070.94
SELL
14 Jan 2020
HOMCY CHARLES J
Chairman of Pharmaceuticals, Director, Officer
BridgeBio Pharma, Inc.
(BBIO)
1,362,291
-0%
10,000
$35.00
$350,000.00
SELL
8 Jan 2020
Turtle Cameron
See Remarks, Officer
BridgeBio Pharma, Inc.
(BBIO)
14,625
-46%
12,807
$34.37
$440,211.00
SELL
2 Jan 2020
HENDERSON MICHAEL THOMAS
See Remarks, Officer
BridgeBio Pharma, Inc.
(BBIO)
178,288
-2%
3,975
$33.17
$131,861.08
SELL
2 Jan 2020
Kumar Neil
See Remarks, Director, Officer
BridgeBio Pharma, Inc.
(BBIO)
2,892,040
-3%
120,000
$32.52
$3,902,416.80
SELL
2 Jan 2020
STEPHENSON BRIAN C
See Remarks, Officer
BridgeBio Pharma, Inc.
(BBIO)
362,652
-2%
10,800
$32.93
$355,683.30
SELL
27 Dec 2019
MCCORMICK FRANK
Chairman of Oncology, Officer
BridgeBio Pharma, Inc.
(BBIO)
1,262,426
-7%
100,000
$37.55
$3,755,379.20
BUY
1 Jul 2019
KKR Genetic Disorder L.P.
10% Owner
BridgeBio Pharma, Inc.
(BBIO)
36,900,660
+7%
2,647,100
$17.00
$45,000,700.00
BUY
1 Jul 2019
HENDERSON MICHAEL THOMAS
See Remarks, Officer
BridgeBio Pharma, Inc.
(BBIO)
180,767
+4%
7,000
$17.00
$119,000.00
BUY
1 Jul 2019
Sinha Uma
Chief Scientific Officer, Officer
BridgeBio Pharma, Inc.
(BBIO)
14,000
+100%
14,000
$17.00
$238,000.00
BUY
1 Jul 2019
STEPHENSON BRIAN C
See Remark, Officer
BridgeBio Pharma, Inc.
(BBIO)
368,446
+17%
55,500
$17.00
$943,500.00
BUY
27 Jun 2019
VIKING GLOBAL PERFORMANCE LLC
10% Owner
BridgeBio Pharma, Inc.
(BBIO)
26,620,992
+21%
4,705,900
$17.00
$80,000,300.00
BUY
27 Jun 2019
VIKING GLOBAL INVESTORS LP
10% Owner
BridgeBio Pharma, Inc.
(BBIO)
26,620,992
+21%
4,705,900
$17.00
$80,000,300.00
Home